Jinah Chu

Jinah Chu

Auto-generated profile, based on publicly available information

Jinah Chu

Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2018 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
JSJongmin Sim
Jongmin Sim
HKHyun Hee Koh
Hyun Hee Koh
SCSangjoon Choi
Sangjoon Choi
JCJinah Chu
Jinah Chu
TKTae Sung Kim
Tae Sung Kim
JHJoungho Han
Joungho Han
Pulmonary nodular lymphoid hyperplasia (PNLH) is a non-neoplastic pulmonary lymphoid disorder that can be mistaken for malignancy on radiography. Herein, we present nine cases of PNLH, emphasizing clinicoradiological findings and histological features. We analyzed radiological and clinicopathological features from the electronic medical records of nine patients (eight females and one male) diagnosed with PNLH. IgG and IgG4 immunohistochemical staining was performed in three patients. Two of the nine patients had experienced tuberculosis 40 and 30 years prior, respectively. Interestingly, none were current smokers, although two were ex-smokers. Three patients complaining of persistent cough underwent computed tomography of the chest. PNLH was incidentally discovered in five patients during examination for other reasons. The remaining patient was diagnosed with the disease following treatment for pneumonia. Imaging studies revealed consolidation or a mass-like lesion in eight patients. First impressions included invasive adenocarcinoma and mucosal-associated lymphoid tissue‒type lymphoma. Aspergillosis was suspected in the remaining patient based on radiological images. Resection was performed in all patients. Microscopically, the lesions consisted of nodular proliferation of reactive germinal centers accompanied by infiltration of neutrophils and macrophages in various degrees and surrounding fibrosis. Ultimately, all nine patients were diagnosed with PNLH and showed no evidence of recurrence on follow-up. PNLH is an uncommon but distinct entity with a benign nature, and understanding the radiological and clinicopathological characteristics of PNLH is important.

15 November 2018 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
JCJinah Chu
Jinah Chu
HBHyunsik Bae
Hyunsik Bae
YSYoujeong Seo
Youjeong Seo
SCSoo Youn Cho
Soo Youn Cho
SKSeok-Hyung Kim
Seok-Hyung Kim
ECEun Yoon Cho
Eun Yoon Cho
In the current American Joint Committee on Cancer staging system of breast cancer, only tumor size determines T-category regardless of whether the tumor is single or multiple. This study evaluated if tumor multiplicity has prognostic value and can be used to subclassify breast cancer. We included 5,758 patients with invasive breast cancer who underwent surgery at Samsung Medical Center, Seoul, Korea, from 1995 to 2012. Patients were divided into two groups according to multiplicity (single, n = 4,744; multiple, n = 1,014). Statistically significant differences in lymph node involvement and lymphatic invasion were found between the two groups (p < .001). Patients with multiple masses tended to have luminal A molecular subtype (p < .001). On Kaplan-Meier survival analysis, patients with multiple masses had significantly poorer disease-free survival (DFS) (p = .016). The prognostic significance of multiplicity was seen in patients with anatomic staging group I and prognostic staging group IA (p = .019 and p = .032, respectively). When targeting patients with T1-2 N0 M0, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative cancer, Kaplan-Meier survival analysis also revealed significantly reduced DFS with multiple cancer (p = .031). The multivariate analysis indicated that multiplicity was independently correlated with worse DFS (hazard ratio, 1.23; 95% confidence interval, 1.03 to 1.47; p = .025). The results of this study indicate that tumor multiplicity is frequently found in luminal A subtype, is associated with frequent lymph node metastasis, and is correlated with worse DFS. Tumor multiplicity has prognostic value and could be used to subclassify invasive breast cancer at early stages. Adjuvant chemotherapy would be necessary for multiple masses of T1-2 N0 M0, hormone-receptor-positive, and HER2-negative cancer.

1 January 2026 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
BSBoram Song
Boram Song
DKDong-Hoe Koo
Dong-Hoe Koo
EKEo Jin Kim
Eo Jin Kim
IDIn-gu Do
In-gu Do
JCJinah Chu
Jinah Chu
SCSeoung Wan Chae
Seoung Wan Chae
Song B, et al. J Gastric Cancer. 2026 Apr;26(2):247-259. https://doi.org/10.5230/jgc.2026.26.e3

30 November 2023 in Journal of Rhinology
Verified
Journal Article
Open access
PDF file
JHJoon-Pyo Hong
Joon-Pyo Hong
SKSung Hun Kang
Sung Hun Kang
JCJinah Chu
Jinah Chu
SBSun-Ju Byeon
Sun-Ju Byeon
HLHyunjoo Lee
Hyunjoo Lee
SHSeok Min Hong
Seok Min Hong
Background and Objectives: Zonulin is a human protein that regulates intercellular tight junctions and increases the permeability of the intestinal epithelium. In light of the increasing focus on zonulin’s role in numerous chronic inflammatory diseases, this study aimed to investigate whether differences exist in serum zonulin levels and bronchial epithelium zonulin expression in vivo between asthma and normal groups, using a mouse model.Methods: Sixteen mice were utilized in this study, divided evenly between the normal and asthma groups. Serum zonulin levels, the expression of zonulin antibody in the bronchial epithelium, and serum cytokine levels were evaluated in both groups. Enzyme-linked immunosorbent assay and RNA in situ hybridization were utilized for the analysis.Results: The asthma group exhibited significantly higher levels of serum zonulin. High zonulin antibody expression was also observed in the bronchial epithelium of the asthma group. Given that our mouse model demonstrated a significant difference in interleukin (IL)-4 and IL-6 between the normal and asthma groups, zonulin may be associated not only with type 2 responses but also with various subtypes of asthma. Further studies are required to investigate this relationship in greater detail.Conclusion: Zonulin may play a role in the complex pathophysiology of asthma and could serve as a biomarker in various asthma-related situations.